z-logo
Premium
Injectable gellan gum hydrogels with autologous cells for the treatment of rabbit articular cartilage defects
Author(s) -
Oliveira João T.,
Gardel Leandro S.,
Rada Tommaso,
Martins Luís,
Gomes Manuela E.,
Reis Rui L.
Publication year - 2010
Publication title -
journal of orthopaedic research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.041
H-Index - 155
eISSN - 1554-527X
pISSN - 0736-0266
DOI - 10.1002/jor.21114
Subject(s) - gellan gum , self healing hydrogels , rabbit (cipher) , articular cartilage , cartilage , tissue engineering , biomedical engineering , materials science , chemistry , anatomy , osteoarthritis , medicine , pathology , polymer chemistry , computer science , food science , alternative medicine , computer security
In this work, the ability of gellan gum hydrogels coupled with autologous cells to regenerate rabbit full‐thickness articular cartilage defects was tested. Five study groups were defined: (a) gellan gum with encapsulated chondrogenic predifferentiated rabbit adipose stem cells (ASC + GF); (b) gellan gum with encapsulated nonchondrogenic predifferentiated rabbit adipose stem cells (ASC); (c) gellan gum with encapsulated rabbit articular chondrocytes (AC) (standard control); (d) gellan gum alone (control); (e) empty defect (control). Full‐thickness articular cartilage defects were created and the gellan gum constructs were injected and left for 8 weeks. The macroscopic aspect of the explants showed a progressive increase of similarity with the lateral native cartilage, stable integration at the defect site, more pronouncedly in the cell‐loaded constructs. Tissue scoring showed that ASC + GF exhibited the best results regarding tissue quality progression. Alcian blue retrieved similar results with a better outcome for the cell‐loaded constructs. Regarding real‐time PCR analyses, ASC + GF had the best progression with an upregulation of collagen type II and aggrecan, and a downregulation of collagen type I. Gellan gum hydrogels combined with autologous cells constitute a promising approach for the treatment of articular cartilage defects, and adipose derived cells may constitute a valid alternative to currently used articular chondrocytes. © 2010 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 28:1193–1199, 2010

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom